Drew Adams

Dr. Adams is an interdisciplinary scientist working at the interface of chemistry and biology. He is an Assistant Professor and the Thomas F. Peterson, Jr. Professor of Novel Therapeutics at Case Western Reserve University School of Medicine in the Department of Genetics and Genome Sciences. His lab recently articulated a central mechanism by which small molecules enhance oligodendrocyte formation and remyelination (Nature, 2018). Dr. Adams completed his BA in biochemistry at Swarthmore College and his PhD in organic chemistry at Harvard University. Before joining CWRU, Dr. Adams' postdoctoral studies with Dr. Stuart Schreiber at the Broad Institute of Harvard and MIT allowed him to develop deep expertise in chemical biology and drug development.